SCO-116 (Eye/Skin)
Fuchs' Dystrophy, Corneal Endothelial Damage, Dry AMD
PreclinicalPartnered
Key Facts
Indication
Fuchs' Dystrophy, Corneal Endothelial Damage, Dry AMD
Phase
Preclinical
Status
Partnered
Company
About SCOHIA PHARMA
A Japanese bioventure developing innovative small molecule drugs for metabolic, cardiovascular, and renal diseases through a diversified pipeline and strategic collaborations.
View full company profile